Shree Ganesh Bio-Tech Quarterly Results for Trading Insights
SHREEGANES • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Shree Ganesh Bio-Tech Quarterly Results Key Highlights
- Revenue of ₹24 Cr in March 2025 (+0.0% vs March 2025, +14.3% vs March 2024)
- Operating Margin of -5.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.01 in March 2025 (+0.0% vs March 2025)
Shree Ganesh Bio-Tech Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8 | 24 | 21 | 63 | 73 | -66.7% | - |
| Net Profit (₹ Cr) | 0 | 0 | 1 | 2 | 3 | - | - |
| EBITDA (₹ Cr) | 0 | 0 | 1 | 3 | 4 | - | - |
| EPS (₹) | 0.00 | 0.01 | 0.02 | 0.05 | 0.13 | - | - |
| Operating Margin (%) | -28.0% | -5.0% | -1.0% | 3.0% | 5.0% | - | - |
Shree Ganesh Bio-Tech Share Price Trend Around Quarterly Results
Visualize Shree Ganesh Bio-Tech's 1-year price movement across quarterly results — ideal for logging trades in Shree Ganesh Bio-Tech share price
chart using Tickjournal. All values in ₹.
Related Pages for Shree Ganesh Bio-Tech
Additional stock information and data for SHREEGANES
Revenue Trend (₹ Cr)
March 2023
63
March 2024
21
March 2025
24
2026
8
Net Profit Trend (₹ Cr)
March 2023
2
March 2024
1
March 2025
0
2026
0
Operating Margin Trend (%)
March 2023
3.0%
March 2024
-1.0%
March 2025
-5.0%
2026
-28.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Shree Ganesh Bio-Tech quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores